PV

Parimal Vadilalbhai Patel

Active Director Director DIN 08181439
DIN 08181439 First appointment Jul 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Parimal Vadilalbhai Patel

Data last updated:

Parimal Vadilalbhai Patel is a Director at Symax Denmed Private Limited (since 2018). The company operates in Business Services.

DIN 08181439
Primary Designation Director
Industry Business Services
First Appointment 17 Jul 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Symax Denmed Private Limited U74999GJ2018PTC103312
Director17 Jul 20182018Active

Board colleagues of Parimal Vadilalbhai Patel

NameDINCompanyDesignation
Kalpesh Shankarlal Mevada02869725Symax Denmed Private LimitedDirector

Directorship timeline

Open interactive timeline →
Symax Denmed Private Limited
Premium access

Shareholding and investment profile for Parimal Vadilalbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parimal Vadilalbhai Patel

Parimal Vadilalbhai Patel currently holds 1 directorship: Symax Denmed Private Limited (Director, since 17 Jul 2018).

Parimal Vadilalbhai Patel was first appointed on 17 Jul 2018 as Director at Symax Denmed Private Limited.

The current boards of Parimal Vadilalbhai Patel's companies include Kalpesh Shankarlal Mevada (Symax Denmed Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available